{"parse":{"title":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use","pageid":1616138,"revid":849647540,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(January 2009)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>The <b>International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use</b> (<b>ICH</b>) is a project that brings together the regulatory authorities of <a href=\"/wiki/Europe\" title=\"Europe\">Europe</a>, <a href=\"/wiki/Japan\" title=\"Japan\">Japan</a> and the <a href=\"/wiki/United_States\" title=\"United States\">United States</a> and experts from the <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">pharmaceutical industry</a> in the three regions to discuss scientific and technical aspects of pharmaceutical product registration.\n</p><p>The purpose of ICH is to reduce or eliminate the need to duplicate the testing carried out during the research and development of new medicines by recommending ways to achieve greater harmonisation in the interpretation and application of technical guidelines and requirements for product registration. Harmonisation would lead to a more economical use of human, non-human animal and material resources, and the elimination of unnecessary delay in the global development and availability of new medicines while maintaining safeguards on quality, safety, and efficacy, and regulatory obligations to protect public health.\n</p><p>ICH guidelines have been adopted as law in several countries, but are only used as guidance for the <a href=\"/wiki/U.S._Food_and_Drug_Administration\" class=\"mw-redirect\" title=\"U.S. Food and Drug Administration\">U.S. Food and Drug Administration</a>.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Structure\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Structure</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Step_2:_Confirmation_of_EWG_consensus_by_the_SC\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Step 2: Confirmation of EWG consensus by the SC</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Step_3:_Regulatory_consultation_and_discussion\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Step 3: Regulatory consultation and discussion</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Step_4:_Adoption_of_an_ICH_harmonised_tripartite_guideline\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Step 4: Adoption of an ICH harmonised tripartite guideline</span></a></li>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Step_5:_Implementation\"><span class=\"tocnumber\">2.4</span> <span class=\"toctext\">Step 5: Implementation</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#See_also\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Notes\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Notes</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In the 1980s, what is today the <a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a> began harmonising regulatory requirements. In 1989, Europe, Japan, and the United States began creating plans for harmonisation; <b>International Council of Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use</b> (ICH) was created in April 1990 at a meeting in <a href=\"/wiki/Brussels\" title=\"Brussels\">Brussels</a>.\n</p><p>In 2015, International Conference on Harmonisation changed its name to the International Council for Harmonisation while becoming a legal entity in Switzerland.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-jliedu_3-0\" class=\"reference\"><a href=\"#cite_note-jliedu-3\">&#91;3&#93;</a></sup> On 23 October 2015 ICH conducted the initial meeting of their new assembly.<sup id=\"cite_ref-jliedu_3-1\" class=\"reference\"><a href=\"#cite_note-jliedu-3\">&#91;3&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Structure\">Structure</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use&amp;action=edit&amp;section=2\" title=\"Edit section: Structure\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The ICH has four major parts:<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p>\n<ol><li>ICH Steering Committee</li>\n<li>ICH Coordinators</li>\n<li>ICH Secretariat</li>\n<li>ICH Working Groups</li></ol>\n<p>The Steering Committee, made of six ICH Parties, governs the ICH, determining the policies and procedures, selecting topics for harmonisation and monitoring progress of harmonisation initiatives. The ICH consists of:\n</p>\n<ul><li><a href=\"/wiki/European_Commission\" title=\"European Commission\">European Commission</a></li>\n<li><a href=\"/wiki/European_Federation_of_Pharmaceutical_Industries_and_Associations\" title=\"European Federation of Pharmaceutical Industries and Associations\">European Federation of Pharmaceutical Industries and Associations</a> (EFPIA)</li>\n<li><a href=\"/wiki/Ministry_of_Health,_Labour_and_Welfare_(Japan)\" class=\"mw-redirect\" title=\"Ministry of Health, Labour and Welfare (Japan)\">Ministry of Health, Labour and Welfare (Japan)</a> (MHLW)</li>\n<li><a href=\"/wiki/Japan_Pharmaceutical_Manufacturers_Association\" title=\"Japan Pharmaceutical Manufacturers Association\">Japan Pharmaceutical Manufacturers Association</a> (JPMA)</li>\n<li><a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA)</li>\n<li><a href=\"/wiki/Pharmaceutical_Research_and_Manufacturers_of_America\" title=\"Pharmaceutical Research and Manufacturers of America\">Pharmaceutical Research and Manufacturers of America</a> (PhRMA)</li></ul>\n<p>The ICH Coordinators represents each ICH Party to the ICH Secretariat on a day-to-day basis.\n</p><p>The ICH Secretariat is primarily concerned with preparations for, and documentation of, meetings of the Steering Committee as well as coordination of preparations for Working Group (EWG (Expert Working Group), IWG (Implementation Working Group), Informal WG) and Discussion Group meetings.\n</p><p>The ICH Working Groups are created by the Steering Committee when a new topic is accepted for harmonisation, and is charged with developing a harmonised guideline that meets the objectives outlined in the Concept Paper and Business Plan.\n</p><p>Face-to-face meetings of the EWG will normally only take place during the biannual SC meetings. Interim reports are made at each meeting of the SC.\n</p><p>If consensus is reached the EWG will sign the <i>Step 2 Experts Signoff</i> sheet and submit it to the SC to request adoption.\nIf there is no agreement in the EWG within the time frame the SC may extend the time frame, suspend or abandon the harmonization project.\n</p>\n<h3><span class=\"mw-headline\" id=\"Step_2:_Confirmation_of_EWG_consensus_by_the_SC\">Step 2: Confirmation of EWG consensus by the SC</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use&amp;action=edit&amp;section=3\" title=\"Edit section: Step 2: Confirmation of EWG consensus by the SC\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Step 2 is reached when the SC agrees, based on the report of the EWG, that there is sufficient scientific consensus on the technical issues for the draft guideline. This text is signed off by the SC as <i>Step 2 Final Document</i>.\n</p>\n<h3><span class=\"mw-headline\" id=\"Step_3:_Regulatory_consultation_and_discussion\">Step 3: Regulatory consultation and discussion</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use&amp;action=edit&amp;section=4\" title=\"Edit section: Step 3: Regulatory consultation and discussion\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The draft becomes subject of consultation in the three regions. It is published in the European Union (as draft <a href=\"/wiki/Committee_for_Medicinal_Products_for_Human_Use\" title=\"Committee for Medicinal Products for Human Use\">CHMP</a> or <a href=\"/w/index.php?title=Committee_for_Medicinal_Products_for_Veterinary_Use&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Committee for Medicinal Products for Veterinary Use (page does not exist)\">CVMP</a> guideline), Japan (after translation by <a href=\"/wiki/MHLW\" class=\"mw-redirect\" title=\"MHLW\">MHLW</a>), and the USA (as draft guideline in the <a href=\"/wiki/Federal_Register\" title=\"Federal Register\">Federal Register</a>) and everybody within these regions can comment on it. There is also an opportunity for companies, associations and authorities in non-ICH regions to comment on the draft, which is distributed by <a href=\"/wiki/IFPMA\" class=\"mw-redirect\" title=\"IFPMA\">IFPMA</a> and <a href=\"/wiki/WHO\" class=\"mw-redirect\" title=\"WHO\">WHO</a>. After obtaining all consultation results, the EWG will be resumed. A new rapporteur will be appointed from the regulatory party, preferably from the same region as the previous rapporteur. The same procedure described in Step 1 is used to address the consultation results into the <i>Step 2 Final Document</i>. The draft document to be generated as a result of the Step 3 phase is called <a href=\"/w/index.php?title=Step_4_Experts_Document&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Step 4 Experts Document (page does not exist)\">Step 4 Experts Document</a>.\n</p><p>If industry and regulatory EWG members agree on the alterations as a result of the consultation, the Step 4 Experts Document is signed by the EWG regulatory experts only (<i>Step 4 Experts Signoff</i>) and submitted to the SC to request adoption as Step 4 of the ICH process.\n</p>\n<h3><span class=\"mw-headline\" id=\"Step_4:_Adoption_of_an_ICH_harmonised_tripartite_guideline\">Step 4: Adoption of an ICH harmonised tripartite guideline</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use&amp;action=edit&amp;section=5\" title=\"Edit section: Step 4: Adoption of an ICH harmonised tripartite guideline\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Step 4 is reached when the SC agrees that there is sufficient scientific consensus on the technical issues.\nIf one industry party has strong objections to the adoption of the guideline due to deviations of the revised draft from the original consensus the regulatory parties may agree that a revised document should be submitted for further consultation. In this case, the EWG discussion may be resumed.\n</p><p>The Step 4 Final Document is signed off by the SC signatories for the regulatory parties of ICH as an <a href=\"/w/index.php?title=ICH_Harmonised_Tripartite_Guideline&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ICH Harmonised Tripartite Guideline (page does not exist)\">ICH Harmonised Tripartite Guideline</a>.\n</p>\n<h3><span class=\"mw-headline\" id=\"Step_5:_Implementation\">Step 5: Implementation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use&amp;action=edit&amp;section=6\" title=\"Edit section: Step 5: Implementation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The ICH Harmonised Tripartite Guideline moves immediately to the final step of the process that is the regulatory implementation. This step is carried out according to the same national/regional procedures that apply to other regional regulatory guidelines and requirements, in the <a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a>, Japan, and the United States.\n</p><p>Information on the regulatory action taken and implementation dates are reported back to the SC and published by the ICH Secretariat on the ICH website and in the annual press statement.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use&amp;action=edit&amp;section=7\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div>\n\n&#32;\n<table class=\"multicol\" role=\"presentation\" style=\"border-collapse: collapse; padding: 0; border: 0; background:transparent; width:100%;\"><tbody><tr>\n<td style=\"width: 50%;text-align: left; vertical-align: top;\">\n<ul><li><a href=\"/wiki/Australia_New_Zealand_Therapeutic_Products_Authority\" title=\"Australia New Zealand Therapeutic Products Authority\">Australia New Zealand Therapeutic Products Authority</a></li>\n<li><a href=\"/wiki/CIOMS_Guidelines\" class=\"mw-redirect\" title=\"CIOMS Guidelines\">CIOMS Guidelines</a></li>\n<li><a href=\"/wiki/Clinical_study_report\" title=\"Clinical study report\">Clinical study report</a></li>\n<li><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trial</a></li>\n<li><a href=\"/wiki/Common_Technical_Document\" title=\"Common Technical Document\">Common Technical Document</a></li>\n<li><a href=\"/wiki/Council_for_International_Organizations_of_Medical_Sciences\" title=\"Council for International Organizations of Medical Sciences\">Council for International Organizations of Medical Sciences</a></li>\n<li><a href=\"/wiki/Good_clinical_practice\" title=\"Good clinical practice\">Good clinical practice</a> (GCP)</li>\n<li><a href=\"/wiki/Health_Canada\" title=\"Health Canada\">Health Canada</a></li>\n<li><a href=\"/wiki/Health_Sciences_Authority\" title=\"Health Sciences Authority\">Health Sciences Authority</a> \u2013 Singapore</li></ul>\n<p>&#32;\n</p>\n</td>\n<td style=\"width: 50%;text-align: left; vertical-align: top;\">\n<ul><li><a href=\"/wiki/IFPMA\" class=\"mw-redirect\" title=\"IFPMA\">IFPMA</a> \u2013 &amp; \u2013 <a href=\"/wiki/International_Pharmaceutical_Federation\" title=\"International Pharmaceutical Federation\">International Pharmaceutical Federation</a></li>\n<li><a href=\"/wiki/National_pharmaceuticals_policy\" class=\"mw-redirect\" title=\"National pharmaceuticals policy\">National pharmaceuticals policy</a></li>\n<li><a href=\"/wiki/Pharmaceutical_policy\" title=\"Pharmaceutical policy\">Pharmaceutical policy</a></li>\n<li><a href=\"/wiki/Pharmacopoeia\" title=\"Pharmacopoeia\">Pharmacopoeia</a></li>\n<li><a href=\"/wiki/Regulation_of_therapeutic_goods\" title=\"Regulation of therapeutic goods\">Regulation of therapeutic goods</a></li>\n<li><a href=\"/wiki/State_Food_and_Drug_Administration\" class=\"mw-redirect\" title=\"State Food and Drug Administration\">State Food and Drug Administration</a> \u2013 China</li>\n<li><a href=\"/wiki/Taiwan_Food_and_Drug_Administration\" class=\"mw-redirect\" title=\"Taiwan Food and Drug Administration\">Taiwan Food and Drug Administration</a><sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup></li>\n<li><a href=\"/wiki/Uppsala_Monitoring_Centre\" title=\"Uppsala Monitoring Centre\">Uppsala Monitoring Centre</a></li></ul>\n<p>&#32;\n</p>\n</td></tr></tbody></table></div>\n<h2><span class=\"mw-headline\" id=\"Notes\">Notes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use&amp;action=edit&amp;section=8\" title=\"Edit section: Notes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Bankert, Elizabeth A; Robert J. Amdur (2006). <i>Institutional Review Board</i>. Jones &amp; Bartlett Publishers. p.&#160;281.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Institutional+Review+Board&amp;rft.pages=281&amp;rft.pub=Jones+%26+Bartlett+Publishers&amp;rft.date=2006&amp;rft.aulast=Bankert&amp;rft.aufirst=Elizabeth+A&amp;rft.au=Robert+J.+Amdur&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Council+for+Harmonisation+of+Technical+Requirements+for+Pharmaceuticals+for+Human+Use\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.raps.org/Regulatory-Focus/News/2015/10/26/23473/ICH-Makes-Organizational-Changes/\">ICH Makes Organizational Changes</a>, Zachary Brennan, 26 October 2015, Regulatory Affairs Professionals Society</span>\n</li>\n<li id=\"cite_note-jliedu-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-jliedu_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-jliedu_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.jliedu.com/blog/ich-is-now-international-council-on-harmonisation-a-legal-swiss-entity/\">ICH is now International Council for Harmonisation \u2013 a Legal Swiss Entity</a>, James Lind Institute</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.ich.org/about/faqs/article/how-is-ich-structured.html\">[1]</a></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ich.org/ichnews/press-releases/view/article/ich-assembly-kobe-japan-june-2018.html\">\"ICH Assembly, Kobe, Japan, June 2018\"</a>. ICH Association. 2018-06-22.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=ICH+Assembly%2C+Kobe%2C+Japan%2C+June+2018&amp;rft.pub=ICH+Association&amp;rft.date=2018-06-22&amp;rft_id=http%3A%2F%2Fwww.ich.org%2Fichnews%2Fpress-releases%2Fview%2Farticle%2Fich-assembly-kobe-japan-june-2018.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Council+for+Harmonisation+of+Technical+Requirements+for+Pharmaceuticals+for+Human+Use\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use&amp;action=edit&amp;section=9\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><span class=\"official-website\"><span class=\"url\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ich.org\">Official website</a></span></span></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://theectdsummit.com/summit/?p=612\">Analysis: New ICH M2 Requirements into eCTD NMV (=RPS)</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1252\nCached time: 20180903185307\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.104 seconds\nReal time usage: 0.154 seconds\nPreprocessor visited node count: 371/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 8651/2097152 bytes\nTemplate argument size: 360/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 3460/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.048/10.000 seconds\nLua memory usage: 2.1 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  127.108      1 -total\n 37.83%   48.091      1 Template:Refimprove\n 37.09%   47.140      1 Template:Reflist\n 24.67%   31.357      1 Template:Ambox\n 23.39%   29.725      1 Template:Cite_book\n 17.47%   22.208      1 Template:Official_website\n  4.34%    5.516      1 Template:Cite_web\n  2.35%    2.987      2 Template:Col-2\n  1.70%    2.162      2 Template:Main_other\n  1.24%    1.582      1 Template:Col-begin\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1616138-0!canonical and timestamp 20180903185307 and revision id 849647540\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%A7%D9%84%D9%85%D8%AC%D9%84%D8%B3_%D8%A7%D9%84%D8%AF%D9%88%D9%84%D9%8A_%D9%84%D8%AA%D9%86%D8%B3%D9%8A%D9%82_%D8%A7%D9%84%D9%85%D8%AA%D8%B7%D9%84%D8%A8%D8%A7%D8%AA_%D8%A7%D9%84%D8%AA%D9%82%D9%86%D9%8A%D8%A9_%D9%84%D9%84%D9%85%D8%B3%D8%AA%D8%AD%D8%B6%D8%B1%D8%A7%D8%AA_%D8%A7%D9%84%D8%B5%D9%8A%D8%AF%D9%84%D8%A7%D9%86%D9%8A%D8%A9_%D9%84%D9%84%D8%A7%D8%B3%D8%AA%D8%AE%D8%AF%D8%A7%D9%85_%D8%A7%D9%84%D8%A8%D8%B4%D8%B1%D9%8A","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0627\u0644\u0645\u062c\u0644\u0633 \u0627\u0644\u062f\u0648\u0644\u064a \u0644\u062a\u0646\u0633\u064a\u0642 \u0627\u0644\u0645\u062a\u0637\u0644\u0628\u0627\u062a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0644\u0644\u0645\u0633\u062a\u062d\u0636\u0631\u0627\u062a \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629 \u0644\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0628\u0634\u0631\u064a"},{"lang":"de","url":"https://de.wikipedia.org/wiki/International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use","langname":"German","autonym":"Deutsch","*":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Conferencia_Internacional_sobre_armonizaci%C3%B3n_de_requisitos_t%C3%A9cnicos_para_el_registro_de_productos_farmac%C3%A9uticos_para_uso_humano","langname":"Spanish","autonym":"espa\u00f1ol","*":"Conferencia Internacional sobre armonizaci\u00f3n de requisitos t\u00e9cnicos para el registro de productos farmac\u00e9uticos para uso humano"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Conseil_international_d%27harmonisation_des_exigences_techniques_pour_l%27enregistrement_des_m%C3%A9dicaments_%C3%A0_usage_humain","langname":"French","autonym":"fran\u00e7ais","*":"Conseil international d'harmonisation des exigences techniques pour l'enregistrement des m\u00e9dicaments \u00e0 usage humain"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Conferenza_internazionale_per_l%27armonizzazione_dei_requisiti_tecnici_per_la_registrazione_dei_farmaci_ad_uso_umano","langname":"Italian","autonym":"italiano","*":"Conferenza internazionale per l'armonizzazione dei requisiti tecnici per la registrazione dei farmaci ad uso umano"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Mi%C4%99dzynarodowa_Rada_Harmonizacji_Wymaga%C5%84_Technicznych_dla_Rejestracji_Produkt%C3%B3w_Leczniczych_Stosowanych_u_Ludzi","langname":"Polish","autonym":"polski","*":"Mi\u0119dzynarodowa Rada Harmonizacji Wymaga\u0144 Technicznych dla Rejestracji Produkt\u00f3w Leczniczych Stosowanych u Ludzi"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E5%9C%8B%E9%9A%9B%E9%86%AB%E8%97%A5%E6%B3%95%E8%A6%8F%E5%8D%94%E5%92%8C%E6%9C%83","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u570b\u969b\u91ab\u85e5\u6cd5\u898f\u5354\u548c\u6703"}],"categories":[{"sortkey":"International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use","hidden":"","*":"Articles_needing_additional_references_from_January_2009"},{"sortkey":"International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use","hidden":"","*":"All_articles_needing_additional_references"},{"sortkey":"International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use","*":"Clinical_research"},{"sortkey":"International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use","*":"Pharmaceuticals_policy"},{"sortkey":"International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use","*":"Drug_safety"},{"sortkey":"International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use","*":"Life_sciences_industry"}],"links":[{"ns":14,"exists":"","*":"Category:Articles needing additional references from January 2009"},{"ns":0,"exists":"","*":"Australia New Zealand Therapeutic Products Authority"},{"ns":0,"exists":"","*":"Brussels"},{"ns":0,"exists":"","*":"CIOMS Guidelines"},{"ns":0,"exists":"","*":"Clinical study report"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Committee for Medicinal Products for Human Use"},{"ns":0,"exists":"","*":"Common Technical Document"},{"ns":0,"exists":"","*":"Council for International Organizations of Medical Sciences"},{"ns":0,"exists":"","*":"Europe"},{"ns":0,"exists":"","*":"European Commission"},{"ns":0,"exists":"","*":"European Federation of Pharmaceutical Industries and Associations"},{"ns":0,"exists":"","*":"European Union"},{"ns":0,"exists":"","*":"Federal Register"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Good clinical practice"},{"ns":0,"exists":"","*":"Health Canada"},{"ns":0,"exists":"","*":"Health Sciences Authority"},{"ns":0,"exists":"","*":"IFPMA"},{"ns":0,"exists":"","*":"International Pharmaceutical Federation"},{"ns":0,"exists":"","*":"Japan"},{"ns":0,"exists":"","*":"Japan Pharmaceutical Manufacturers Association"},{"ns":0,"exists":"","*":"MHLW"},{"ns":0,"exists":"","*":"Ministry of Health, Labour and Welfare (Japan)"},{"ns":0,"exists":"","*":"National pharmaceuticals policy"},{"ns":0,"exists":"","*":"Pharmaceutical Research and Manufacturers of America"},{"ns":0,"exists":"","*":"Pharmaceutical industry"},{"ns":0,"exists":"","*":"Pharmaceutical policy"},{"ns":0,"exists":"","*":"Pharmacopoeia"},{"ns":0,"exists":"","*":"Regulation of therapeutic goods"},{"ns":0,"exists":"","*":"State Food and Drug Administration"},{"ns":0,"exists":"","*":"Taiwan Food and Drug Administration"},{"ns":0,"exists":"","*":"U.S. Food and Drug Administration"},{"ns":0,"exists":"","*":"United States"},{"ns":0,"exists":"","*":"Uppsala Monitoring Centre"},{"ns":0,"exists":"","*":"WHO"},{"ns":0,"*":"Committee for Medicinal Products for Veterinary Use"},{"ns":0,"*":"Step 4 Experts Document"},{"ns":0,"*":"ICH Harmonised Tripartite Guideline"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":12,"exists":"","*":"Help:Introduction to referencing with Wiki Markup/1"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Refimprove"},{"ns":10,"exists":"","*":"Template:More citations needed"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Col-begin"},{"ns":10,"exists":"","*":"Template:Col-2"},{"ns":10,"exists":"","*":"Template:Col-break"},{"ns":10,"exists":"","*":"Template:Col-end"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Official website"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Official website"},{"ns":828,"exists":"","*":"Module:URL"}],"images":["Question_book-new.svg"],"externallinks":["http://www.raps.org/Regulatory-Focus/News/2015/10/26/23473/ICH-Makes-Organizational-Changes/","http://www.jliedu.com/blog/ich-is-now-international-council-on-harmonisation-a-legal-swiss-entity/","http://www.ich.org/about/faqs/article/how-is-ich-structured.html","http://www.ich.org/ichnews/press-releases/view/article/ich-assembly-kobe-japan-june-2018.html","http://www.ich.org","http://theectdsummit.com/summit/?p=612"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use","byteoffset":1361,"anchor":"History"},{"toclevel":1,"level":"2","line":"Structure","number":"2","index":"2","fromtitle":"International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use","byteoffset":2431,"anchor":"Structure"},{"toclevel":2,"level":"3","line":"Step 2: Confirmation of EWG consensus by the SC","number":"2.1","index":"3","fromtitle":"International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use","byteoffset":4224,"anchor":"Step_2:_Confirmation_of_EWG_consensus_by_the_SC"},{"toclevel":2,"level":"3","line":"Step 3: Regulatory consultation and discussion","number":"2.2","index":"4","fromtitle":"International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use","byteoffset":4508,"anchor":"Step_3:_Regulatory_consultation_and_discussion"},{"toclevel":2,"level":"3","line":"Step 4: Adoption of an ICH harmonised tripartite guideline","number":"2.3","index":"5","fromtitle":"International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use","byteoffset":5812,"anchor":"Step_4:_Adoption_of_an_ICH_harmonised_tripartite_guideline"},{"toclevel":2,"level":"3","line":"Step 5: Implementation","number":"2.4","index":"6","fromtitle":"International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use","byteoffset":6426,"anchor":"Step_5:_Implementation"},{"toclevel":1,"level":"2","line":"See also","number":"3","index":"7","fromtitle":"International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use","byteoffset":6976,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"Notes","number":"4","index":"8","fromtitle":"International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use","byteoffset":7913,"anchor":"Notes"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"9","fromtitle":"International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use","byteoffset":7936,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use","iwlinks":[],"properties":[{"name":"defaultsort","*":"International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use"},{"name":"wikibase_item","*":"Q1666462"}]}}